| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |